Full Text
PDF
Abstract
INTRODUCTION: In this study, we aimed to evaluate the long term prognosis and real life data of patients with HBsAg positivity and inactive carriers.
METHODS: Inactive hepatitis B carrier 1147 patients whom are under follow-up of out-patient chronic hepatitis clinic of Health Science University, Izmir Bozyaka Training and Research Hospital Infectious Diseases Unit from 1994-2018 were included in the study. The patients files were analysed for socio-demographical information, signs of disease and laboratory findings at the begining and during the follow-up period and all data were collected and recorded to Excell programme. As a second step, patients that did not attend to control examinations for more than one year were called and a questionnaire form were filled by either on phone calls or face to face interwievs.
FINDINGS: Of 1147 patients, 50.5% were men and the mean age was 50,17±12. When current statuses of 1147 patients were evaluated: 73% were still inactive carriers, 2% were under anti-viral treatment, 11% had acute inflammation of the disease, 13.6% had spontaneous HBsAg clearence (16.2 per 1000 patient years) and 0.5% had cirrhosis and/or hepatocellular carcinoma. When coherence to control visits were evaluted,60% of inactive carriers were not attending regularly to controls and only 6.5% attended to control visits after they were called. Among patients with acute inflammation of the disease, 53% were not attending regularly to controls and only 4% attended to control visits after they were called. Among patients that were under anti-viral treatment, 63,6% were still attending to controls. When HBV-DNA situations were evaluated: In 15% inactive carriers, in 91% of patients that are under anti-viral treatment, in 72% of patients with acute inflammation and 6% of patients with spontaneous HBsAg clearence HBV-DNA levels reached to ≥104 copy/ml or≥2000 IU/ml at least for once during the follow-up period. When results of abdominal ultrasonographies at the begining and at the last patient visit were evaluated: In two patients (%0,2) a mass lesion of the liver and in one patient (0.1%) a cirrhotic pattern was developed.Presence of hepatosteosis reached from 20% to 25%, hepatomegaly reached to 2% to 6% and splenomegaly reached to 0.8% to 1.1%.
CONCLUSION: As long term prognosis of inactive HBsAg carriers are not still well known and still few studies exists in the literature, we believe that more studies should be performed comprising long term follow-up results of those patients. The fact that inactive carriers are mostly asymphtomatic, only laboratory tests are performed at their control visits and no medications are introduced for their disease, make them to believe they are not really ill so underestimate their situation. As the risk of HCC and/or cirrhosis still does exist, acute inflammations and so a need for anti-viral treatment may appear in years, emphasizing the importance of treatment compliance to those pateints is important.
Most read articles by the same author(s)
- Tansu Yamazhan, Esra Zerdali, Yusuf Önlen, Selma Tosun, Özgür Günal, Ayşe Batırel, İmran Hasanoğlu, Tuba Turunç, Umay Balcı, Sibel Yıldız Kaya, Oğuz Karabay, İlknur Esen Yıldız, Lütfiye Nilsun Altunal, Hacer Deniz Özkaya, Selçuk Kaya, Ayşe İnci, Sevil Alkan, Dilek Sevgi Yıldız, Tayibe Bal, Esma Aslıhan Aydemir, Nurullah Eser, Serhat Uysal, Oğuzhan Acet, Fehmi Tabak, Rahmet Güner, A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate , Turkish Journal of Gastroenterology: Vol. 37 No. 2 (2026): Turkish Journal of Gastroenterology
- Yusuf Önlen, Tayibe Bal, Mehmet Çabalak, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Ebubekir Şenateş, Alper Gündüz, Esra Zerdali, Hasan Karsen, Ayşe Batırel, Rıdvan Karaali, Rahmet Güner, Tansu Yamazhan, Şükran Köse, Nurettin Erben, Nevin İnce, İftihar Köksal, Figen Sarıgül Yıldırım, Gülşen Yörük, Süheyla Kömür, Sibel Kaya, Şaban Esen, Özgür Günal, İlknur Esen Yıldız, Dilara İnan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Şener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Esragül Akıncı, Güray Can, Ülkü User, Hanefi Cem Gül, Ayhan Akbulut, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak, Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey , Turkish Journal of Gastroenterology: Vol. 33 No. 10 (2022): Turkish Journal of Gastroenterology
- Fehmi Tabak, Cihan Yurdaydın, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Alper Gunduz, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Senates, Esra Zerdali, Hasan Karsen, Ayse Batırel, Rıdvan Kara Ali, Rahmet Güner, Tansu Yamazhan, Sukran Kose, Nurettin Erben, Nevin Ince, İftihar Köksal, Figen Sarıgül Yıldırım, Gulsen Yoruk, Suheyla Komur, Tayibe Bal, Sibel Kaya, Şaban Esen, Özgür Günal, Ilknur Esen Yıldız, Dilara Inan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Sener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Esragül Akıncı, Güray Can, Ulku User, Hanefi Cem Gül, Ayhan Akbulut, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak, Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye , Turkish Journal of Gastroenterology: Vol. 37 No. 6 (2026): Turkish Journal of Gastroenterology
- Cihan Yurdaydın, Fehmi Tabak, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Figen Sarıgül Yıldırım, Ülkü Üser, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Şenateş, Alper Gündüz, Esra Zerdali, Hasan Karsen, Ayşe Batırel, Rıdvan Karaali, Rahmet Güner, Tansu Yamazhan, Şükran Köse, Nurettin Erben, Nevin İnce, İftihar Köksal, Nefise Çuvalcı Öztoprak, Gülşen Yörük, Süheyla Kömür, Tayibe Bal, Sibel Kaya, İlkay Bozkurt, Özgür Günal, İlknur Esen Yıldız, Dilara İnan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Şener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Hürrem Bodur, Güray Can, Hanefi Cem Gül, Ayşe Sağmak Tartar, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak, In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey , Turkish Journal of Gastroenterology: Vol. 33 No. 11 (2022): Turkish Journal of Gastroenterology
- Zehra Karacaer, Selma Tosun, Ayşe Batırel, Suzan Şahin, İrem Altaş, Serhat Uysal, Serpil Erol, Nurgül Ceran, Ayşe Albayrak, İlknur Esen Yıldız, Uğur Kostakoğlu, Fatma Kaçar, Nuretdin Kuzhan, Ayten Kadanalı, Gül Karagöz, Ercan Yenilmez, Derya Bayırlı Turan, Arzu Altunçekiç Yıldırım, Funda Koçak, Rıza Aytaç Çetinkaya, Mehmet Parlak, Özlem Aydın, Pınar Ergen, Gül Durmuş, Türkkan Öztürk Kaygusuz, Özgur Dağlı, Canan Demir, Fatma Yılmaz Karadağ, Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study , Turkish Journal of Gastroenterology: Vol. 29 No. 2 (2018): Turkish Journal of Gastroenterology
- Selma Tosun, Seher Ayten Coskuner, Irem Altas, Diagnosis ways of chronic HBV cases , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Selma Tosun, Seher Ayten Coskuner, Hulya Bayık, Long-term impact on health vocational high school students 20 years after national HBV vaccination , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Fehmi Tabak, Behice Kurtaran, Esra Zerdali, Selma Tosun, Şaban Esen, Nefie Çuvalcı Öztoprak, Kamuran Türker, Nagehan Didem Sarı, Yusuf Önlen, Tansu Yamazhan, Kenan Hızel, Hepcturkey Study Group, Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 30 · Issue Supplement 1
Pages
55-55
History
Published Online
July 25, 2019
Copyright
Copyright (c) 2019 Irem Altas, Selma Tosun
Affiliations
Irem Altas
Health Science University Izmir Bozyaka Education and Resarch Hospital Department of Infectious Diseases and Clinical Microbiology Izmir
Selma Tosun
Health Science University Izmir Bozyaka Education and Resarch Hospital Department of Infectious Diseases and Clinical Microbiology Izmir
Cite this Article
Altas, I., & Tosun, S. (2019). Evaluation of 24-year followig results of patients with inactive hepatitis B. Turkish Journal of Gastroenterology, 30(Supplement 1), 55–55. https://doi.org/10.5152/tjg.2019.35
Outlines